Table 3 Postoperative recurrence of 250 rectal cancer patients who underwent TME with or without LPND up to 3 years after surgery in matching cohort
TME (n = 125) | TME + LPND (n = 125) | P | |
|---|---|---|---|
Overall recurrence (%) | 12 (9.6) | 21 (16.8) | 0.093 |
Local recurrence | 5 (4.0) | 6 (4.8) | 0.758 |
Distant metastasis | 9 (7.2) | 19 (15.2) | 0.044 |
Liver metastasis | 5 (4.0) | 11 (8.8) | |
Lung metastasis | 4 (3.1) | 8 (6.3) | |
Bone metastasis | 4 (3.1) | 5 (4.0) | |
Peritoneal metastasis | 0 (0) | 1 (0.8) | |
Brain metastasis | 1 (0.8) | 0 (0) | |
Others | 1 (0.8) | 2 (1.6) |